Insufficient scRNA-seq data for expression of KCNMB3 at single-cell level.
Insufficient scRNA-seq data for expression of KCNMB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 260.02 | 459 / 459 | 53% | 0.97 | 590 / 1118 |
esophagus | 98% | 151.38 | 1414 / 1445 | 49% | 0.85 | 90 / 183 |
lung | 98% | 125.88 | 569 / 578 | 39% | 0.82 | 452 / 1155 |
uterus | 100% | 210.12 | 170 / 170 | 28% | 0.48 | 128 / 459 |
ovary | 100% | 145.91 | 180 / 180 | 22% | 0.32 | 93 / 430 |
bladder | 100% | 172.48 | 21 / 21 | 21% | 0.37 | 105 / 504 |
pancreas | 100% | 216.70 | 328 / 328 | 18% | 0.31 | 32 / 178 |
prostate | 100% | 250.75 | 245 / 245 | 16% | 0.20 | 80 / 502 |
liver | 100% | 155.54 | 225 / 226 | 13% | 0.24 | 54 / 406 |
stomach | 100% | 177.69 | 359 / 359 | 13% | 0.23 | 36 / 286 |
intestine | 100% | 185.07 | 966 / 966 | 11% | 0.17 | 58 / 527 |
kidney | 100% | 157.26 | 89 / 89 | 9% | 0.15 | 79 / 901 |
thymus | 100% | 215.10 | 653 / 653 | 5% | 0.07 | 33 / 605 |
adrenal gland | 100% | 178.60 | 258 / 258 | 4% | 0.07 | 10 / 230 |
spleen | 100% | 353.73 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 219.56 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 146.59 | 1329 / 1335 | 0% | 0 | 0 / 0 |
brain | 92% | 64.57 | 2433 / 2642 | 7% | 0.13 | 51 / 705 |
heart | 96% | 93.52 | 828 / 861 | 0% | 0 | 0 / 0 |
skin | 90% | 84.98 | 1623 / 1809 | 5% | 0.09 | 24 / 472 |
muscle | 66% | 34.62 | 531 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.46 | 16 / 29 |
peripheral blood | 41% | 56.77 | 381 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.21 | 7 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006813 | Biological process | potassium ion transport |
GO_0001508 | Biological process | action potential |
GO_0019228 | Biological process | neuronal action potential |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0005513 | Biological process | detection of calcium ion |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0015269 | Molecular function | calcium-activated potassium channel activity |
GO_0015459 | Molecular function | potassium channel regulator activity |
Gene name | KCNMB3 |
Protein name | Calcium-activated potassium channel subunit beta-3 (BK channel subunit beta-3) (BKbeta3) (Hbeta3) (Calcium-activated potassium channel, subfamily M subunit beta-3) (Charybdotoxin receptor subunit beta-3) (K(VCA)beta-3) (Maxi K channel subunit beta-3) (Slo-beta-3) Alternative protein KCNMB3 Calcium-activated potassium channel subunit beta (BKbeta) (BK channel subunit beta) (Calcium-activated potassium channel, subfamily M subunit beta) (Charybdotoxin receptor subunit beta) (K(VCA)beta) (Maxi K channel subunit beta) (Slo-beta) |
Synonyms | KCNMBL KCNMB2 |
Description | FUNCTION: Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Alters the functional properties of the current expressed by the KCNMA1 channel. Isoform 2, isoform 3 and isoform 4 partially inactivate the current of KCNBMA. Isoform 4 induces a fast and incomplete inactivation of KCNMA1 channel that is detectable only at large depolarizations. In contrast, isoform 1 does not induce detectable inactivation of KCNMA1. Two or more subunits of KCNMB3 are required to block the KCNMA1 tetramer. . FUNCTION: Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. . |
Accessions | ENST00000392686.6 [Q9NPA1-4] ENST00000392685.7 [Q9NPA1-3] ENST00000497599.5 [Q9NPA1-5] ENST00000349697.2 [Q9NPA1-2] A0A087WV41 ENST00000486944.2 ENST00000314235.9 [Q9NPA1-1] L8E9P7 ENST00000485523.5 [Q9NPA1-4] Q9NPA1 |